In this study, our objectives were twofold: first, to provide a comparison of the effects of three inotropic agents (dobutamine, dopamine, and epinephrine) during the period immediately following emergence from cardiopulmonary bypass; and second, to make recommendations regarding appropriate methods of monitoring the efficacy of inotropic drug administration in this specific situation.
studied immediately following cessation of cardiopulmonary bypass in 34 patients with preoperative evidence of left ventricular dysfunction. Significant increases in mean cardiac index were seen with dobutamine (15, 25 , and 26% respectively), and epinephrine (30%).
The largest increases occurred with dopamine (44, 53, and 64 percent respectively). Responses varied from patient to patient, however. Seven patients developed marked output increases without concomi-MANY STUDIES OF We previously reported" that dobutamine was associated tant increases in arterial pressure, whereas seven others showed "satisfying" increases in arterial pressure without appreciable output increases. Heart rate increases were small and few arrhythmias were noted. We conclude that dopamine, epinephrine, and dobutamine all are effective inotropic agents during the immediate post-bypass period, with variations discussed in detail. None possess the disturbing chronotropic and arrhythmogenic effects of isoproterenol (previously studied). Efficacy of administration of inotropic drugs seems best assessed by serial output measurements during this period.
with moderate increases in cardiac index without significant heart rate increases, in sharp contrast to isoproterenol. Isoproterenol (0.02 jAg/kg/min) caused a mean heart rate increase of 43.9%, with multiple premature ventricular contractions, and little change in output. In this study, our objectives were twofold: first, to provide a comparison of the effects of three inotropic agents (dobutamine, dopamine, and epinephrine) during the period immediately following emergence from cardiopulmonary bypass; and second, to make recommendations regarding appropriate methods of monitoring the efficacy of inotropic drug administration in this specific situation.
Methods
Thirty-four patients were studied, usually with two of the three drugs in each patient. Dopamine and dobutamine were usually studied in two infusion rates, epinephrine in one infusion rate. This resulted in 56 patient-inotropic drug exposures, and a total of 81 Results No significant differences in any measured parameters were noted to depend upon whether a drug was given first or second in the sequence, therefore all results for each drug are taken together. For the first drug dose (10,ug/kg/min for dopamine and dobutamine; 0.04 Ag/kg/min for epinephrine) data reported were obtained after the 10-min test period. For the second dose of dopamine and dobutamine (5 and 15 Ag/kg/min) data reported were obtained after 5 min.
Epinephrine 0.04 Ag/kg/min was studied in ten patients; dobutamine 5 ,ug/kg/min in 11 patients, 10 jg/kg/min in 17 patients, 15 Ag/kg/min in ten patients; dopamine 5 ,ug/kg/min in seven patients, 10 ,ug/kg/min in 20 patients, and 15 ,Mg/kg/min in six patients.
Cardiac Index (CI)
Most but not all patients responded to the inotropic drugs with an increase in cardiac index (table 2, fig. 1 ). In three instances, during infusion of dobutamine 5 ,Mg/kg/min, three instances during infusion of dobutamine 10 ,Mg/kg/min (total of four different patients), and in one patient receiving dopamine 10 ,g/kg/min, there was no increase or a slight decrease in cardiac index. In each instance of failure to respond to either dobutamine or dopamine, cardiac index did increase in response to the other drug. There were no instances in which epinephrine failed to elicit an increase in cardiac index. fig. 2 ). With dopamine, the mean increases with the same doses were respectively 33%, 21%, and 30%, and the increase with epinephrine 0.04 ,g/kg/min was 27%. All mean values were significantly different from the appropriate control values (P < 0.01 except dobutamine 15 ,g/kg/min with P < 0.05).
Pulse Pressure
Mean pulse pressures increased 25%, 39%, and 30% with dobutamine, 5, 10, and 15 gig/kg/min respectively (table 2) .
With dopamine, the mean increases were respectively 52%, 46%, and 42% and the increase with epinephrine was 75% (P < 0.05 for dobutamine 5 and 15 gg, P < 0.01 for the rest).
Heart Rate (HR) Mean HR increased 10%, 7% and 7% for dobutamine 5, 10 and 15 ,ug/kg/min respectively (table 3, fig. 3 ). For dopamine the mean increases were respectively 9%, 12%, and 13%. With epinephrine 0.04 Ag/kg/min, the mean increase in HR was I 1%. The increase for dobutamine 5 and 10 and dopamine 10 ,g/kg/min had a P value < 0.05, the other heart rate changes were not significant at the P < 0.05 level. The only significant change in mean SVR seen with any of the three drugs in any dosage was a 15% decrease with dopamine 10 ,ug/kg/min (P < 0.01) ( fig. 4 ). With dopamine the increases were respectively 82%, 74%, and 93%, and the increase for epinephrine was 52%. (P < 0.05 for epinephrine, for the other values P < 0.01). dosage was reduced, lidocaine administered, and the arrhythmias did not recur. One patient had a short run of bigeminy during dobutamine infusion. Occasional PVCs were seen in most patients in all groups, most commonly with surgical manipulation. Qualitative differences between the three agents with regard to arrhythmogenicity were not apparent.
Blood Gas, Acid Base, and Electrolyte Balance Mean values are listed in table 4. All patients had adequate blood gas, acid-base, and electrolyte values.
Discussion
Emergence from cardiopulmonary bypass is a unique situation with obvious potential for unstable hemodynamics. Results of any study conducted during this period must be interpreted with caution. This is, however, a period during which inotropic drugs are commonly, often uncritically, used. Changes in cardiac output are due to bleeding, changing ventricular function, and peripheral resistance, combined with anesthetics. Because bleeding can be considerable during this period, we chose to transfuse in order to maintain constant left atrial pressure; thus increases in output after inotropic drug infusion reflect increased inotropic state at constant preload. Return of output to ± 10% of control values after discontinuance of inotropic drugs in all cases is evidence that output changes reported were predominantly due to the inotropic agents themselves.
The dosages 5, 10 and 15 Ag/kg/min for dopamine4 [7] [8] [9] [10] and dobutaminel 2, 5,6 11 were chosen because similar dosages were used in previous reports in other situations, and to compare potencies. In open chest dogs, Tuttle and Mills12 found dobutamine to be four times more potent than dopamine with respect to increasing contractile tension, yet Loeb et al. 9 reported that dopamine was twice as potent as dobutamine in increasing cardiac output in patients with chronic low output. The epinephrine dosage of 0.04 ,gg/kg/min was chosen because pilot studies indicated that it would cause cardiac output increases similar to those caused by 10 ,ug/kg/min dobutamine. The arterial pressure increases noted with all three drugs are in agreement with most studies 5 6 8, 10,11,14, 15 although some investigations4 8 18 have not observed significant increases in MAP with dopamine or dobutamine. Despite the larger output increases seen with dopamine, the increase in MAP with this drug was not significantly higher than that for dobutamine or epinephrine. This is interpreted as indicating a greater tendency of dopamine to produce peripheral vasodilation, although a significant (P < 0.01) decrease in calculated systemic vascular resistance was found with the 10 Mg/kg/min dose of dopamine only. The Another property of isoproterenol which may set it apart from the three drugs studied herein is the fact that the skeletal muscular vasodilation caused by it may divert the increased output (wastefully) to that tissue.'2 '7 Isoproterenol has been reported to induce enough skeletal muscle vasodilation to actually decrease MAP (and coronary perfusion).' 12, 20 With respect to comparisons between dopamine, dobutamine, and epinephrine, dopamine resulted in the largest increases in cardiac index at the chosen dosages during emergence from bypass. However, it also resulted in systemic vascular dilation. This may not be desirable during this critical period because of the resultant increase in myocardial oxygen requirement. Renal sure. This has negative implications, especially after aortic valve replacement, because of increased bleeding and possible compromise of aortic suture line integrity by inordinately high systolic pressure. Monitoring arterial and atrial pressures only, as is common practice, proved to be unreliable in assessing efficacy of inotropic drug administration. There were seven instances in which little or no increase in mean arterial pressure was noted during the inotropic drug administration, yet cardiac index increased markedly. There were, by contrast, seven other instances in which the inotropic agent led to "satisfying" arterial pressure increases with little or no increase in cardiac index. We could not single out any of the three drugs as more likely to be associated with such a disparity.
Cardiac index increases observed in this study
Increasing cardiac output and arterial pressure with inotropic drug alone may not be wise if myocardial oxygen supply/demand ratio is unfavorably affected. Oxygen demand is increased with inotropic agent-induced increases in contractility, heart rate, and aortic pressure. In some patients it seems beneficial to reduce aortic pressure with vasodilators alone. In other circumstances, vasodilators must be combined with inotropic drug to maintain adequate perfusion pressure. No studies including vasodilators during emergence from bypass have yet been reported. We do not imply that inotropic drug administration, even if accompanied by satisfying increases in output and pressure, is necessarily beneficial. Inotropic drugs are probably needed when severe myocardial failure occurs during the emergence period.
We conclude the following: 1) dopamine, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Ag/kg/min; dobutamine, 5-15 ,ug/kg/min; and epinephrine, 0.04 ,ug/kg/min, all are suitable for inotropic support during emergence from cardiopulmonary bypass, to produce increases in cardiac index at constant left atrial pressures, small increases in heart rate, and no severe arrhythmias; 2) dopamine appears about twice as potent as dobutamine for this purpose, although dobutamine appears to be more cardioselective; 3) considerable variance in individual patient responses should be expected. It is recommended that cardiac performance during the period immediately following bypass is best assessed by serial measurements of cardiac output. Reliance upon left atrial and arterial pressures alone may be inadequate, especially for evaluation of the results of inotropic drug administration.
